J
Jasenka Demirovic
Researcher at University of Texas Health Science Center at Houston
Publications - 8
Citations - 3616
Jasenka Demirovic is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Dementia & Mass screening. The author has an hindex of 5, co-authored 8 publications receiving 3429 citations. Previous affiliations of Jasenka Demirovic include University of Texas System.
Papers
More filters
Journal ArticleDOI
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
Morteza Naghavi,Erling Falk,Harvey S. Hecht,Michael J. Jamieson,Sanjay Kaul,Daniel S. Berman,Zahi A. Fayad,Matthew J. Budoff,John A. Rumberger,Tasneem Z. Naqvi,Leslee J. Shaw,Ole Faergeman,Jay N. Cohn,Raymond D. Bahr,Wolfgang Koenig,Jasenka Demirovic,Dan E. Arking,Victoria L. M. Herrera,Juan J. Badimon,James A. Goldstein,Yoram Rudy,Juhani Airaksinen,Robert S. Schwartz,Ward A. Riley,Robert A. Mendes,Pamela S. Douglas,Prediman K. Shah +26 more
TL;DR: The Screening for Heart Attack Prevention and Education (SHAPE) Task Force presents a new practice guideline for cardiovascular screening in the asymptomatic at-risk population, calling for noninvasive screening of all asymptonomatic men 45‐75 years of age and asymPTomatic women 55‐75years of age to detect and treat those with subclinical atherosclerosis.
Journal ArticleDOI
Prevalence of dementia in three ethnic groups: the South Florida program on aging and health.
Jasenka Demirovic,Ronald J. Prineas,David A. Loewenstein,Judy A. Bean,Ranjan Duara,Steven Sevush,José Szapocznik +6 more
TL;DR: A population sample of 2,759 elderly (65 years of age and older) African American, Hispanic-Cuban and white non-Hispanic men and women of Dade County, Florida examined to determine the prevalence of cognitive impairment and dementia in a multi-ethnic community.
Journal ArticleDOI
Changing Patient Characteristics and Survival Experience in an Alzheimer’s Center Patient Cohort
Rachelle S. Doody,Valory N. Pavlik,Paul J. Massman,Mary M. Kenan,Stephanie Yeh,Suzanne Zein-Eldin Powell,Norma Cooke,Carmel B. Dyer,Jasenka Demirovic,Stephen C. Waring,Wenyaw Chan +10 more
TL;DR: Careful analyses of those who continue and those who drop out from follow-up suggest that atypical diagnosis, rather than severity or demographic issues accounts for most of the attrition.
Journal ArticleDOI
Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
Rachelle S. Doody,Jasenka Demirovic,Christie M. Ballantyne,Wenyaw Chan,Robert Barber,Suzanne Zein-Eldin Powell,Valory N. Pavlik +6 more
TL;DR: Lipoprotein‐associated phospholipase A2 and homocysteine have been linked to inflammation and Alzheimer's disease and their independent effects and interactions with cardiovascular disease equivalent (CVDE) are examined.